Zobrazeno 1 - 10
of 306
pro vyhledávání: '"prime-boost immunization"'
Autor:
Antonia Radaelli, Carlo Zanotto, Chiara Brambilla, Tommaso Adami, Francesca Paolini, Aldo Venuti, Adriana Manuka, Irsida Mehmeti, Carlo De Giuli Morghen
Publikováno v:
Virology Journal, Vol 21, Iss 1, Pp 1-12 (2024)
Highlights Recombinant avipoxviruses as putative recombinant vaccines against MPXV. Different prime–boost regimens to improve immunization against orthopoxviruses. Mucosal and intramuscular immunization to enhance the humoral and neutralizing immun
Externí odkaz:
https://doaj.org/article/1c1531897baa4c83a54eca993ea56772
Autor:
Hiroki Uchiyama, Toshifumi Kudo, Takehiro Yamaguchi, Nozomu Obana, Kenji Watanabe, Kimihiro Abe, Hidetaka Miyazaki, Masanori Toyofuku, Nobuhiko Nomura, Yukihiro Akeda, Ryoma Nakao
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTThere is a growing interest in development of novel vaccines against respiratory tract infections, due to COVID-19 pandemic. Here, we examined mucosal adjuvanticity and the mucosal booster effect of membrane vesicles (MVs) of a novel probioti
Externí odkaz:
https://doaj.org/article/f9ac0a5cea9a47029ede47ea185d23ea
Sex differences in immune protection in mice conferred by heterologous vaccines for pneumonic plague
Autor:
Michael L. Davies, Sergei S. Biryukov, Nathaniel O. Rill, Christopher P. Klimko, Melissa Hunter, Jennifer L. Dankmeyer, Jeremy A. Miller, Jennifer L. Shoe, Kevin D. Mlynek, Yuli Talyansky, Ronald G. Toothman, Ju Qiu, Joel A. Bozue, Christopher K. Cote
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundYersinia pestis is the etiological agent of plague, which can manifest as bubonic, septicemic, and/or pneumonic disease. Plague is a severe and rapidly progressing illness that can only be successfully treated with antibiotics initiated ear
Externí odkaz:
https://doaj.org/article/32e4ce5d271c4416bfa144b9a94b89b9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Luigi Aurisicchio, Arthur Fridman, David Mauro, Rose Sheloditna, Alberto Chiappori, Ansuman Bagchi, Gennaro Ciliberto
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-8 (2020)
Abstract Background Human telomerase reverse transcriptase (hTERT) is an antigen that may represent a target for a novel anti-cancer strategy. A pilot, phase I study tested the safety and feasibility of a prime-boost immunization regimen based on V93
Externí odkaz:
https://doaj.org/article/aab4e0ed9d5a4db4b9b409327d52c706
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The efficacy of COVID-19 vaccines appears to depend in complex ways on the vaccine dosage and the interval between the prime and boost doses. Unexpectedly, lower dose prime and longer prime-boost intervals have yielded higher efficacies in clinical t
Externí odkaz:
https://doaj.org/article/56051e2f77a54102a8ed5191ba0c60a4
Publikováno v:
Инфекция и иммунитет, Vol 9, Iss 1, Pp 67-75 (2019)
Avian influenza A (H1N1) in humans is characterized by severe clinical manifestation and high mortality. The main drawback of current human H5N1 vaccines is related to low immunogenicity. Prime-boost vaccination is considered as an effective approach
Externí odkaz:
https://doaj.org/article/37f3fc5a738741eea67975ee79e4b01b
Publikováno v:
Frontiers in Medical Technology, Vol 3 (2021)
Dengue infections still have a tremendous impact on public health systems in most countries in tropical and subtropical regions. The disease is systemic and dynamic with broad range of manifestations, varying from mild symptoms to severe dengue (Deng
Externí odkaz:
https://doaj.org/article/8e2a742cc4614eea92ccd3127b7638c3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.